Emerging  ||| S:0 E:9 ||| VBG
antimicrobial  ||| S:9 E:23 ||| JJ
resistance  ||| S:23 E:34 ||| NN
in  ||| S:34 E:37 ||| IN
commensal  ||| S:37 E:47 ||| JJ
Escherichia  ||| S:47 E:59 ||| JJ
coli  ||| S:59 E:64 ||| NNS
with  ||| S:64 E:69 ||| IN
public  ||| S:69 E:76 ||| JJ
health  ||| S:76 E:83 ||| NN
relevance  ||| S:83 E:93 ||| NN
In  ||| S:93 E:96 ||| IN
2009 ||| S:96 E:100 ||| CD
,  ||| S:100 E:102 ||| ,
1462  ||| S:102 E:107 ||| CD
Escherichia  ||| S:107 E:119 ||| JJ
coli  ||| S:119 E:124 ||| JJ
isolates  ||| S:124 E:133 ||| NN
were  ||| S:133 E:138 ||| VBD
collected  ||| S:138 E:148 ||| VBN
in  ||| S:148 E:151 ||| IN
a  ||| S:151 E:153 ||| DT
systematic  ||| S:153 E:164 ||| JJ
resistance  ||| S:164 E:175 ||| NN
monitoring  ||| S:175 E:186 ||| NN
approach  ||| S:186 E:195 ||| NN
from  ||| S:195 E:200 ||| IN
primary  ||| S:200 E:208 ||| JJ
production ||| S:208 E:218 ||| NN
,  ||| S:218 E:220 ||| ,
slaughterhouses  ||| S:220 E:236 ||| NN
and  ||| S:236 E:240 ||| CC
at  ||| S:240 E:243 ||| IN
retail  ||| S:243 E:250 ||| JJ
and  ||| S:250 E:254 ||| CC
evaluated  ||| S:254 E:264 ||| VBN
on  ||| S:264 E:267 ||| IN
the  ||| S:267 E:271 ||| DT
basis  ||| S:271 E:277 ||| NN
of  ||| S:277 E:280 ||| IN
epidemiological  ||| S:280 E:296 ||| JJ
cut-off  ||| S:296 E:304 ||| JJ
values ||| S:304 E:310 ||| NNS
.  ||| S:310 E:312 ||| .
Besides  ||| S:312 E:320 ||| IN
resistance  ||| S:320 E:331 ||| NN
to  ||| S:331 E:334 ||| TO
antimicrobial  ||| S:334 E:348 ||| VB
classes  ||| S:348 E:356 ||| NNS
that  ||| S:356 E:361 ||| WDT
have  ||| S:361 E:366 ||| VBP
been  ||| S:366 E:371 ||| VBN
extensively  ||| S:371 E:383 ||| RB
used  ||| S:383 E:388 ||| VBN
for  ||| S:388 E:392 ||| IN
a  ||| S:392 E:394 ||| DT
long  ||| S:394 E:399 ||| JJ
time  ||| S:399 E:404 ||| NN
( ||| S:404 E:405 ||| -LRB-
e.g.  ||| S:405 E:410 ||| CD
sulphonamides  ||| S:410 E:424 ||| NNS
and  ||| S:424 E:428 ||| CC
tetracyclines ||| S:428 E:441 ||| CD
) ||| S:441 E:442 ||| -RRB-
,  ||| S:442 E:444 ||| ,
resistance  ||| S:444 E:455 ||| NN
to  ||| S:455 E:458 ||| TO
( ||| S:458 E:459 ||| -LRB-
fluoro ||| S:459 E:465 ||| LS
) ||| S:465 E:466 ||| -RRB-
quinolones  ||| S:466 E:477 ||| NN
and  ||| S:477 E:481 ||| CC
third-generation  ||| S:481 E:498 ||| JJ
cephalosporins  ||| S:498 E:513 ||| NN
was  ||| S:513 E:517 ||| VBD
observed ||| S:517 E:525 ||| VBN
.  ||| S:525 E:527 ||| .
While  ||| S:527 E:533 ||| IN
in  ||| S:533 E:536 ||| IN
the  ||| S:536 E:540 ||| DT
poultry  ||| S:540 E:548 ||| JJ
production  ||| S:548 E:559 ||| NN
chain  ||| S:559 E:565 ||| NN
the  ||| S:565 E:569 ||| DT
majority  ||| S:569 E:578 ||| NN
( ||| S:578 E:579 ||| -LRB-
60 ||| S:579 E:581 ||| CD
% ||| S:581 E:582 ||| NN
)  ||| S:582 E:584 ||| -RRB-
of  ||| S:584 E:587 ||| IN
isolates  ||| S:587 E:596 ||| NN
from  ||| S:596 E:601 ||| IN
laying  ||| S:601 E:608 ||| VBG
hens  ||| S:608 E:613 ||| NNS
was  ||| S:613 E:617 ||| VBD
susceptible  ||| S:617 E:629 ||| JJ
to  ||| S:629 E:632 ||| TO
all  ||| S:632 E:636 ||| DT
antimicrobials  ||| S:636 E:651 ||| JJ
tested ||| S:651 E:657 ||| NN
,  ||| S:657 E:659 ||| ,
most  ||| S:659 E:664 ||| RBS
isolates  ||| S:664 E:673 ||| JJ
from  ||| S:673 E:678 ||| IN
broilers ||| S:678 E:686 ||| NN
,  ||| S:686 E:688 ||| ,
chicken  ||| S:688 E:696 ||| NN
meat  ||| S:696 E:701 ||| NN
and  ||| S:701 E:705 ||| CC
turkey  ||| S:705 E:712 ||| JJ
meat  ||| S:712 E:717 ||| NN
showed  ||| S:717 E:724 ||| VBD
resistance  ||| S:724 E:735 ||| NN
to  ||| S:735 E:738 ||| TO
at  ||| S:738 E:741 ||| IN
least  ||| S:741 E:747 ||| JJS
one  ||| S:747 E:751 ||| CD
( ||| S:751 E:752 ||| -LRB-
85-93 ||| S:752 E:757 ||| NNP
% ||| S:757 E:758 ||| NN
)  ||| S:758 E:760 ||| -RRB-
but  ||| S:760 E:764 ||| CC
frequently  ||| S:764 E:775 ||| RB
even  ||| S:775 E:780 ||| RB
to  ||| S:780 E:783 ||| TO
several  ||| S:783 E:791 ||| JJ
antimicrobial  ||| S:791 E:805 ||| JJ
classes  ||| S:805 E:813 ||| NNS
( ||| S:813 E:814 ||| -LRB-
73-84 ||| S:814 E:819 ||| NNP
% ||| S:819 E:820 ||| NN
) ||| S:820 E:821 ||| -RRB-
.  ||| S:821 E:823 ||| .
In  ||| S:823 E:826 ||| IN
the  ||| S:826 E:830 ||| DT
cattle  ||| S:830 E:837 ||| NNS
and  ||| S:837 E:841 ||| CC
pig  ||| S:841 E:845 ||| JJ
production  ||| S:845 E:856 ||| NN
chain ||| S:856 E:861 ||| NN
,  ||| S:861 E:863 ||| ,
the  ||| S:863 E:867 ||| DT
share  ||| S:867 E:873 ||| NN
of  ||| S:873 E:876 ||| IN
isolates  ||| S:876 E:885 ||| JJ
showing  ||| S:885 E:893 ||| NN
resistance  ||| S:893 E:904 ||| NN
to  ||| S:904 E:907 ||| TO
at  ||| S:907 E:910 ||| IN
least  ||| S:910 E:916 ||| JJS
one  ||| S:916 E:920 ||| CD
antimicrobial  ||| S:920 E:934 ||| NNS
was  ||| S:934 E:938 ||| VBD
lowest  ||| S:938 E:945 ||| JJS
( ||| S:945 E:946 ||| -LRB-
16 ||| S:946 E:948 ||| CD
% ||| S:948 E:949 ||| NN
)  ||| S:949 E:951 ||| -RRB-
in  ||| S:951 E:954 ||| IN
dairy  ||| S:954 E:960 ||| NN
cows ||| S:960 E:964 ||| NNS
,  ||| S:964 E:966 ||| ,
whereas  ||| S:966 E:974 ||| IN
resistance  ||| S:974 E:985 ||| NN
to  ||| S:985 E:988 ||| TO
at  ||| S:988 E:991 ||| IN
least  ||| S:991 E:997 ||| JJS
one  ||| S:997 E:1001 ||| CD
antimicrobial  ||| S:1001 E:1015 ||| NNS
ranged  ||| S:1015 E:1022 ||| VBD
between  ||| S:1022 E:1030 ||| IN
43 ||| S:1030 E:1032 ||| CD
%  ||| S:1032 E:1034 ||| NN
and  ||| S:1034 E:1038 ||| CC
73 ||| S:1038 E:1040 ||| CD
%  ||| S:1040 E:1042 ||| NN
in  ||| S:1042 E:1045 ||| IN
veal  ||| S:1045 E:1050 ||| JJ
calves ||| S:1050 E:1056 ||| NNS
,  ||| S:1056 E:1058 ||| ,
veal  ||| S:1058 E:1063 ||| NN
and  ||| S:1063 E:1067 ||| CC
pork ||| S:1067 E:1071 ||| NN
.  ||| S:1071 E:1073 ||| .
Resistance  ||| S:1073 E:1084 ||| NN
rates  ||| S:1084 E:1090 ||| NNS
to  ||| S:1090 E:1093 ||| TO
ciprofloxacin  ||| S:1093 E:1107 ||| VB
and  ||| S:1107 E:1111 ||| CC
nalidixic  ||| S:1111 E:1121 ||| JJ
acid  ||| S:1121 E:1126 ||| NN
in  ||| S:1126 E:1129 ||| IN
isolates  ||| S:1129 E:1138 ||| NN
from  ||| S:1138 E:1143 ||| IN
broilers  ||| S:1143 E:1152 ||| NN
were  ||| S:1152 E:1157 ||| VBD
41.1 ||| S:1157 E:1161 ||| CD
%  ||| S:1161 E:1163 ||| NN
and  ||| S:1163 E:1167 ||| CC
43.1 ||| S:1167 E:1171 ||| CD
% ||| S:1171 E:1172 ||| NN
,  ||| S:1172 E:1174 ||| ,
respectively ||| S:1174 E:1186 ||| RB
.  ||| S:1186 E:1188 ||| .
Likewise ||| S:1188 E:1196 ||| RB
,  ||| S:1196 E:1198 ||| ,
high  ||| S:1198 E:1203 ||| JJ
resistance  ||| S:1203 E:1214 ||| NN
rates  ||| S:1214 E:1220 ||| NNS
to  ||| S:1220 E:1223 ||| TO
( ||| S:1223 E:1224 ||| -LRB-
fluoro ||| S:1224 E:1230 ||| LS
) ||| S:1230 E:1231 ||| -RRB-
quinolones  ||| S:1231 E:1242 ||| NN
were  ||| S:1242 E:1247 ||| VBD
observed  ||| S:1247 E:1256 ||| VBN
in  ||| S:1256 E:1259 ||| IN
isolates  ||| S:1259 E:1268 ||| NN
from  ||| S:1268 E:1273 ||| IN
chicken  ||| S:1273 E:1281 ||| NN
meat  ||| S:1281 E:1286 ||| NN
and  ||| S:1286 E:1290 ||| CC
turkey  ||| S:1290 E:1297 ||| JJ
meat ||| S:1297 E:1301 ||| NN
.  ||| S:1301 E:1303 ||| .
In  ||| S:1303 E:1306 ||| IN
contrast ||| S:1306 E:1314 ||| NN
,  ||| S:1314 E:1316 ||| ,
ciprofloxacin  ||| S:1316 E:1330 ||| JJ
resistance  ||| S:1330 E:1341 ||| NN
was  ||| S:1341 E:1345 ||| VBD
less  ||| S:1345 E:1350 ||| RBR
frequent  ||| S:1350 E:1359 ||| JJ
in  ||| S:1359 E:1362 ||| IN
E. coli  ||| S:1362 E:1370 ||| CD
isolates  ||| S:1370 E:1379 ||| NN
from  ||| S:1379 E:1384 ||| IN
the  ||| S:1384 E:1388 ||| DT
cattle  ||| S:1388 E:1395 ||| NNS
and  ||| S:1395 E:1399 ||| CC
pig  ||| S:1399 E:1403 ||| JJ
production  ||| S:1403 E:1414 ||| NN
chain  ||| S:1414 E:1420 ||| NN
with  ||| S:1420 E:1425 ||| IN
highest  ||| S:1425 E:1433 ||| JJS
rate  ||| S:1433 E:1438 ||| NN
in  ||| S:1438 E:1441 ||| IN
veal  ||| S:1441 E:1446 ||| JJ
calves  ||| S:1446 E:1453 ||| NNS
( ||| S:1453 E:1454 ||| -LRB-
13.3 ||| S:1454 E:1458 ||| CD
% ||| S:1458 E:1459 ||| NN
) ||| S:1459 E:1460 ||| -RRB-
.  ||| S:1460 E:1462 ||| .
Highest  ||| S:1462 E:1470 ||| JJS
resistance  ||| S:1470 E:1481 ||| NN
rates  ||| S:1481 E:1487 ||| NNS
to  ||| S:1487 E:1490 ||| TO
cephalosporins  ||| S:1490 E:1505 ||| NNS
were  ||| S:1505 E:1510 ||| VBD
observed  ||| S:1510 E:1519 ||| VBN
in  ||| S:1519 E:1522 ||| IN
broilers  ||| S:1522 E:1531 ||| NN
and  ||| S:1531 E:1535 ||| CC
chicken  ||| S:1535 E:1543 ||| NN
meat ||| S:1543 E:1547 ||| NN
,  ||| S:1547 E:1549 ||| ,
with  ||| S:1549 E:1554 ||| IN
5.9 ||| S:1554 E:1557 ||| CD
%  ||| S:1557 E:1559 ||| NN
and  ||| S:1559 E:1563 ||| CC
6.2 ||| S:1563 E:1566 ||| CD
%  ||| S:1566 E:1568 ||| NN
of  ||| S:1568 E:1571 ||| IN
the  ||| S:1571 E:1575 ||| DT
isolates  ||| S:1575 E:1584 ||| NN
showing  ||| S:1584 E:1592 ||| VBG
resistance ||| S:1592 E:1602 ||| NN
.  ||| S:1602 E:1604 ||| .
In  ||| S:1604 E:1607 ||| IN
dairy  ||| S:1607 E:1613 ||| NN
cattle  ||| S:1613 E:1620 ||| NNS
and  ||| S:1620 E:1624 ||| CC
veal ||| S:1624 E:1628 ||| NN
,  ||| S:1628 E:1630 ||| ,
no  ||| S:1630 E:1633 ||| DT
isolates  ||| S:1633 E:1642 ||| NN
with  ||| S:1642 E:1647 ||| IN
cephalosporin  ||| S:1647 E:1661 ||| JJ
resistance  ||| S:1661 E:1672 ||| NN
were  ||| S:1672 E:1677 ||| VBD
detected ||| S:1677 E:1685 ||| VBN
,  ||| S:1685 E:1687 ||| ,
whereas  ||| S:1687 E:1695 ||| IN
3.3 ||| S:1695 E:1698 ||| CD
%  ||| S:1698 E:1700 ||| NN
of  ||| S:1700 E:1703 ||| IN
the  ||| S:1703 E:1707 ||| DT
isolates  ||| S:1707 E:1716 ||| NN
from  ||| S:1716 E:1721 ||| IN
veal  ||| S:1721 E:1726 ||| JJ
calves  ||| S:1726 E:1733 ||| NNS
showed  ||| S:1733 E:1740 ||| VBD
resistance  ||| S:1740 E:1751 ||| NN
to  ||| S:1751 E:1754 ||| TO
ceftazidime ||| S:1754 E:1765 ||| VB
.  ||| S:1765 E:1767 ||| .
Resistance  ||| S:1767 E:1778 ||| NN
to  ||| S:1778 E:1781 ||| TO
( ||| S:1781 E:1782 ||| -LRB-
fluoro ||| S:1782 E:1788 ||| LS
) ||| S:1788 E:1789 ||| -RRB-
quinolones  ||| S:1789 E:1800 ||| NN
and  ||| S:1800 E:1804 ||| CC
cephalosporins  ||| S:1804 E:1819 ||| NN
in  ||| S:1819 E:1822 ||| IN
E. coli  ||| S:1822 E:1830 ||| CD
isolates  ||| S:1830 E:1839 ||| NN
is  ||| S:1839 E:1842 ||| VBZ
of  ||| S:1842 E:1845 ||| IN
special  ||| S:1845 E:1853 ||| JJ
concern  ||| S:1853 E:1861 ||| NN
because  ||| S:1861 E:1869 ||| IN
they  ||| S:1869 E:1874 ||| PRP
are  ||| S:1874 E:1878 ||| VBP
critically  ||| S:1878 E:1889 ||| RB
important  ||| S:1889 E:1899 ||| JJ
antimicrobials  ||| S:1899 E:1914 ||| NN
in  ||| S:1914 E:1917 ||| IN
human  ||| S:1917 E:1923 ||| JJ
antimicrobial  ||| S:1923 E:1937 ||| JJ
therapy ||| S:1937 E:1944 ||| NN
.  ||| S:1944 E:1946 ||| .
The  ||| S:1946 E:1950 ||| DT
emergence  ||| S:1950 E:1960 ||| NN
of  ||| S:1960 E:1963 ||| IN
this  ||| S:1963 E:1968 ||| DT
resistance  ||| S:1968 E:1979 ||| NN
warrants  ||| S:1979 E:1988 ||| NNS
increased  ||| S:1988 E:1998 ||| VBD
monitoring ||| S:1998 E:2008 ||| NN
.  ||| S:2008 E:2010 ||| .
Together  ||| S:2010 E:2019 ||| RB
with  ||| S:2019 E:2024 ||| IN
continuous  ||| S:2024 E:2035 ||| JJ
monitoring  ||| S:2035 E:2046 ||| NN
of  ||| S:2046 E:2049 ||| IN
antimicrobial  ||| S:2049 E:2063 ||| JJ
usage ||| S:2063 E:2068 ||| NN
,  ||| S:2068 E:2070 ||| ,
management  ||| S:2070 E:2081 ||| NN
strategies  ||| S:2081 E:2092 ||| NNS
should  ||| S:2092 E:2099 ||| MD
be  ||| S:2099 E:2102 ||| VB
regularly  ||| S:2102 E:2112 ||| RB
assessed  ||| S:2112 E:2121 ||| VBN
and  ||| S:2121 E:2125 ||| CC
adapted ||| S:2125 E:2132 ||| VBD
.  ||| S:2132 E:2134 ||| .
